2.46
+0.06(+2.50%)
Currency In USD
| Previous Close | 2.4 |
| Open | 2.43 |
| Day High | 2.48 |
| Day Low | 2.38 |
| 52-Week High | 6.08 |
| 52-Week Low | 1.9 |
| Volume | 707,490 |
| Average Volume | 962,463 |
| Market Cap | 197.5M |
| PE | -3.07 |
| EPS | -0.8 |
| Moving Average 50 Days | 2.71 |
| Moving Average 200 Days | 3.16 |
| Change | 0.06 |
If you invested $1000 in Codexis, Inc. (CDXS) 10 years ago, it would be worth $771.16 as of September 29, 2025 at a share price of $2.46. Whereas If you bought $1000 worth of Codexis, Inc. (CDXS) shares 5 years ago, it would be worth $205 as of September 29, 2025 at a share price of $2.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Codexis to Participate in Cantor Global Healthcare Conference
GlobeNewswire Inc.
Aug 28, 2025 1:00 PM GMT
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor
Codexis to Report Second Quarter 2025 Financial Results on August 13
GlobeNewswire Inc.
Jul 30, 2025 8:05 PM GMT
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
GlobeNewswire Inc.
May 22, 2025 11:00 AM GMT
Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases Management to host conference call today at 8 am Eastern Time to discuss data REDWOOD CITY, Ca